WHITEHAWK THERAPEUTICS, INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
WHITEHAWK THERAPEUTICS, INC. (WHWK) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$8.50 thousand for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-15.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2018-05-15
- WHITEHAWK THERAPEUTICS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2018-03-31 was -$8.50K.
- WHITEHAWK THERAPEUTICS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-12-31 was $47.65K.
- WHITEHAWK THERAPEUTICS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-09-30 was $0.00.
- WHITEHAWK THERAPEUTICS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was -$4.34K.
- WHITEHAWK THERAPEUTICS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2017 was $41.10K.
- WHITEHAWK THERAPEUTICS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$113.30K.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2018-03-31 | -$8.50K 10-Q · filed 2018-05-15 | $39.15K derived: sum of 2 quarters · filed 2018-05-15 | $39.15K derived: sum of 3 quarters · filed 2018-05-15 | $34.81K derived: sum of 4 quarters · filed 2018-05-15 |
| 2017-12-31 | $47.65K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $47.65K derived: sum of 2 quarters · filed 2018-03-15 | $43.31K derived: sum of 3 quarters · filed 2018-03-15 | $41.10K 10-K · filed 2018-03-15 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | -$4.34K derived: sum of 2 quarters · filed 2017-11-13 | -$6.55K 10-Q · filed 2017-11-13 | -$6.55K derived: sum of 4 quarters · filed 2018-05-15 |
| 2017-06-30 | -$4.34K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | -$6.55K 10-Q · filed 2017-08-10 | -$6.55K derived: sum of 3 quarters · filed 2018-05-15 | -$6.55K derived: sum of 4 quarters · filed 2018-05-15 |
| 2017-03-31 | -$2.21K 10-Q · filed 2018-05-15 | -$2.21K derived: sum of 2 quarters · filed 2018-05-15 | -$2.21K derived: sum of 3 quarters · filed 2018-05-15 | -$5.06K derived: sum of 4 quarters · filed 2018-05-15 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $0.00 derived: sum of 2 quarters · filed 2018-03-15 | -$2.85K derived: sum of 3 quarters · filed 2018-03-15 | -$113.30K 10-K · filed 2018-03-15 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | -$2.85K derived: sum of 2 quarters · filed 2017-11-13 | -$113.30K 10-Q · filed 2017-11-13 | |
| 2016-06-30 | -$2.85K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | -$113.30K 10-Q · filed 2017-08-10 | ||
| 2016-03-31 | -$110.45K 10-Q · filed 2017-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |